TY  - BOOK
AU  - Walden,Peter
ED  - European Conference on Gene Therapy of Cancer
TI  - Gene therapy of cancer
SN  - 9780306460272
U1  - 616.9940426 21
PY  - 1998///
CY  - New York
PB  - Plenum Press
KW  - Cancer
KW  - Gene therapy
KW  - Congresses
KW  - Neoplasms
KW  - therapy
KW  - congresses
KW  - Gene Therapy
KW  - methods
KW  - immunology
KW  - Gene Targeting
KW  - Clinical Trials
N1  - Contents;

Tumor biology 
1. Expression genetics in cancer research, prognosis and therapy 
2. Patterns of chromosomal imbalances in carcinomas of the respiratory tract 
3. Inhibition of tumorigenesis in murine B-cell lymphoma transplant model 
4. Telomerase inhibition by induced expression of antisense RNA 
5. Ex vivo and in vivo IGF-I antisense RNA strategies for treatment of cancer in humans 
etc.

Chemogene therapy 
16. Intratumoral injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapy 
17. Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. 
18. HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosis 
19. Characteristics of cytosine deaminase-5-fluorocytosine system: Enhancement of radiation cytotoxicity and bystander effect 
20. Potentiation of the bystander effect by immunization combined with suicide gene therapy 
etc.

Tumor immunology 
26. Overcoming T cell ignorance by providing costimulation: Implications for the immune response against cancer 
27. Immune cells in the tumor micorenvironment: Mechanisms responsible for functional and signaling defects 
28. Dendritic cells prevent CD95  mediated T lymphocyte death through costimulatory signals 
29. Interleukin-10 inhibits the immune stimulatory potential of melanoma cells retrovirally tansduced with human 
30. Immunosuppressive cells in bone marrow of patients with stomach cancer 
etc. 

Immunogene therapy 
40. Human tumor immunotherapy: New opportunities as well as new challenges 
41. Modification of cancer vaccines by virus infection and attachment of bispecific antibodies: An effective alternative to somatic gene therapy 
42. Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines 
43. Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by Vero apoptosis 
44. Hybrid cell vaccination in cancer immunotherapy: Recruitment and activation of T cell help for induction of anti tumour cytotoxic T cells 
etc.


; Includes bibliographical references and indexes
UR  - http://www.loc.gov/catdir/enhancements/fy0819/98039294-d.html
UR  - http://www.loc.gov/catdir/enhancements/fy0819/98039294-t.html
ER  -